David Linetsky Sells 3,944 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 3,944 shares of the firm’s stock in a transaction that occurred on Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total value of $94,064.40. Following the completion of the sale, the senior vice president now directly owns 221,738 shares of the company’s stock, valued at $5,288,451.30. This represents a 1.75 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

David Linetsky also recently made the following trade(s):

• On Tuesday, March 18th, David Linetsky sold 39 shares of Phreesia stock. The stock was sold at an average price of $26.95, for a total value of $1,051.05.
• On Thursday, February 13th, David Linetsky sold 11,616 shares of Phreesia stock. The shares were sold at an average price of $29.70, for a total value of $344,995.20.
• On Friday, February 7th, David Linetsky sold 300 shares of Phreesia stock. The stock was sold at an average price of $29.52, for a total transaction of $8,856.00.
• On Wednesday, February 5th, David Linetsky sold 720 shares of Phreesia stock. The stock was sold at an average price of $29.50, for a total transaction of $21,240.00.
• On Wednesday, January 29th, David Linetsky sold 500 shares of Phreesia stock. The shares were sold at an average price of $29.68, for a total transaction of $14,840.00.
• On Monday, January 27th, David Linetsky sold 11,685 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total value of $321,103.80.

Phreesia Stock Performance

Shares of PHR opened at $24.09 on Friday. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $30.53. The company’s 50 day simple moving average is $26.66 and its 200 day simple moving average is $24.25. The company has a market capitalization of $1.42 billion, a price-to-earnings ratio of -16.39 and a beta of 0.82. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Canaccord Genuity Group lifted their price objective on Phreesia from $34.00 to $35.00 and gave the stock a “buy” rating in a report on Thursday, March 13th. Citigroup lifted their price target on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research note on Friday, January 10th. Piper Sandler reiterated an “overweight” rating and issued a $33.00 price objective (up from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Needham & Company LLC restated a “buy” rating and set a $29.00 target price on shares of Phreesia in a report on Thursday, March 13th. Finally, KeyCorp lifted their target price on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 8th. Twelve analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia has a consensus rating of “Buy” and a consensus price target of $31.33.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of PHR. Johnson Financial Group Inc. grew its position in shares of Phreesia by 381.3% in the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after purchasing an additional 896 shares during the period. R Squared Ltd acquired a new stake in Phreesia in the 4th quarter worth about $30,000. BankPlus Trust Department acquired a new stake in Phreesia in the 4th quarter worth about $34,000. Quarry LP grew its holdings in Phreesia by 210.9% in the 4th quarter. Quarry LP now owns 2,835 shares of the company’s stock valued at $71,000 after buying an additional 1,923 shares during the period. Finally, Venturi Wealth Management LLC acquired a new position in shares of Phreesia during the 4th quarter valued at about $76,000. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.